CTRI/2018/07/014767招募中3 期
A randomized controlled trial to evaluate the safety of breast conserving surgery post neoadjuvant therapy
试验速览
- 阶段
- 3 期
- 状态
- 招募中
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •All women with biopsy proven T3/T4 Any N, Or Any T N2/N3 breast cancer who have received neo-adjuvant systemic therapy and are now deemed suitable for BCS
- •Women more than 18yrs
- •Patients who have given consent to participate in the study
排除标准
- •Patients presenting to TMH, post excision Biopsy
- •Patients who show disease progression despite chemotherapy
- •Pregnant women/Lactating women.
- •Inflammatory Breast Cancer
- •Patients not keen on breast conservation.
研究者
相似试验
招募中
不适用
A randomized controlled trial to evaluate the safety and efficacy of an 8-week home-based standardized exercise training program for preventing post-pulmonary embolism syndrome: the PE@HOME studypulmonary embolismNL-OMON54292eids Universitair Medisch Centrum156
招募中
不适用
Point of CARE testing in a general practice setting trialHyperlipidaemia and anticoagulantm therapyMetabolic and Endocrine - DiabetesDiet and Nutrition - Other diet and nutrition disordersDiabetesACTRN12605000272695Department of General Practice, The University of Adelaide6,836
招募中
不适用
A randomized controlled trial evaluating the safety and efficacy of the endovascular treatment of subjects with stenotic or restenotic lesions of the common femoral artery with the Supera Vascular Mimetic Implant compared to surgical Common Femoral Artery Endarterectomyperipheral arterial diseaseNL-OMON55275ID3 Medical40
已完成
不适用
Topical cyclosporine 2% for herpetic interstitial keratitisIRCT2015052112724N2Vice chancellor for research, Isfahan University of Medical Sciences48
招募中
2 期
An Open-Label, Multi-Center, Randomized Study Evaluating the Safety and Efficacy of Flutcasone Propionate Nasal Drops, Nasal Spray and Suspension for Nebulization via Nasal Inhalation in Post-Surgical Subjects with Chronic SinusitisChronic SinusitisInflammatory and Immune System - Other inflammatory or immune system disordersACTRN12608000140358aryx Pharma, Inc.30